Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

4,776 questions · 7,311 findings · 959 reviews · Headline outcomes only

No studies found 1,498 · 20.5%GRADE not reported 303 · 4.1%Very low 1,839 · 25.2%Low 1,991 · 27.2%Moderate 1,277 · 17.5%High 403 · 5.5%

Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.

Chemotherapy with bevacizumab followed by bevacizumab maintenance vs chemotherapy alone

Adverse events (grade ≥ 3) · newly‐diagnosed EOC

Chemotherapy with bevacizumab followed by maintenance bevacizumab probably leads to higher any adverse event grade ≥ 3 compared with chemotherapy alone (moderate certainty).

1 finding from 1 review

Chemotherapy with TKI (peptide‐Fc fusion protein) followed by TKI maintenance vs chemotherapy alone

Overall survival (OS) · newly‐diagnosed EOC

Chemotherapy with TKI (peptide‐Fc fusion protein) followed by TKI… showed no clear difference in overall survival (OS) compared with chemotherapy alone (moderate certainty).

1 finding from 1 review

Chemotherapy with TKI (peptide‐Fc fusion protein) followed by TKI maintenance vs chemotherapy alone

Progression‐free survival (PSF) · newly‐diagnosed EOC

Chemotherapy with TKI (peptide‐Fc fusion protein) followed by TKI… showed no clear difference in progression‐free survival (PSF) compared with chemotherapy alone (moderate certainty).

1 finding from 1 review

Chemotherapy with TKI (peptide‐Fc fusion protein) followed by TKI maintenance vs chemotherapy alone

Adverse events (grade ≥ 3) · newly‐diagnosed EOC

Chemotherapy with TKI (peptide‐Fc fusion protein) followed by TKI… probably leads to lower any adverse event grade ≥ 3 compared with chemotherapy alone (moderate certainty).

1 finding from 1 review

Reactive gel surfaces on operating tables followed by foam surfaces on ward beds vs alternating pressure (active) air surfaces on operating tables and subsequently on ward beds

Proportion of participants developing a new pressure ulcer · preventing pressure ulcers

Reactive gel surfaces on operating tables followed by foam surfaces… may leads to higher proportion of participants developing a new pressure ulcer compared with alternating pressure (active) air surfaces on operating tables and… (low certainty).

1 finding from 1 review

Reactive gel surfaces on operating tables followed by foam surfaces on ward beds vs alternating pressure (active) air surfaces on operating tables and subsequently on ward beds

Time to pressure ulcer development · preventing pressure ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Reactive gel surfaces on operating tables followed by foam surfaces on ward beds vs alternating pressure (active) air surfaces on operating tables and subsequently on ward beds

Support surface associated patient comfort · preventing pressure ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Reactive gel surfaces on operating tables followed by foam surfaces on ward beds vs alternating pressure (active) air surfaces on operating tables and subsequently on ward beds

Health‐related quality of life · preventing pressure ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Reactive gel surfaces on operating tables followed by foam surfaces on ward beds vs alternating pressure (active) air surfaces on operating tables and subsequently on ward beds

Cost‐effectiveness · preventing pressure ulcers

The review found no eligible studies for this question.

1 finding from 1 review

Low dose CNI calcineurin inhibitor (CNI) + mammalian target of rapamycin inhibitor (mTORi) vs standard dose CNI

Death · kidney transplant recipients

Low dose CNI calcineurin inhibitor (CNI) + mammalian target of… showed no clear difference in death compared with standard dose CNI (moderate certainty).

1 finding from 1 review

Low dose CNI calcineurin inhibitor (CNI) + mammalian target of rapamycin inhibitor (mTORi) vs standard dose CNI

Acute rejection · kidney transplant recipients

Low dose CNI calcineurin inhibitor (CNI) + mammalian target of… showed no clear difference in acute rejection compared with standard dose CNI (moderate certainty).

1 finding from 1 review